BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34258813)

  • 1. Efficacy of Lactobacillus vaginal suppositories for the prevention of recurrent cystitis: A phase II clinical trial.
    Sadahira T; Wada K; Araki M; Mitsuhata R; Yamamoto M; Maruyama Y; Iwata T; Watanabe M; Watanabe T; Kariyama R; Nasu Y; Ishii A
    Int J Urol; 2021 Oct; 28(10):1026-1031. PubMed ID: 34258813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II Clinical Trial Evaluating the Preventive Effectiveness of Lactobacillus Vaginal Suppositories in Patients with Recurrent Cystitis.
    Wada K; Uehara S; Ishii A; Sadahira T; Yamamoto M; Mitsuhata R; Takamoto A; Araki M; Kobayashi Y; Watanabe M; Watanabe T; Hotta K; Nasu Y
    Acta Med Okayama; 2016 Aug; 70(4):299-302. PubMed ID: 27549677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology of recurrent cystitis in postmenopausal women based on vaginal microbiota and the role of
    Sekito T; Wada K; Ishii A; Iwata T; Matsubara T; Tomida S; Watanabe M; Araki M; Sadahira T
    Front Microbiol; 2023; 14():1187479. PubMed ID: 37275169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection.
    Uehara S; Monden K; Nomoto K; Seno Y; Kariyama R; Kumon H
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S30-4. PubMed ID: 16859900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women.
    Czaja CA; Stapleton AE; Yarova-Yarovaya Y; Stamm WE
    Infect Dis Obstet Gynecol; 2007; 2007():35387. PubMed ID: 18288237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can vaginal lactobacillus suppositories help reduce urinary tract infections?
    Shoureshi PS; Niino C; Eilber KS
    Int Urogynecol J; 2023 Nov; 34(11):2713-2718. PubMed ID: 37392226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Probiotic SYNBIO(®) Administered by Vaginal Suppositories in Promoting Vaginal Health of Apparently Healthy Women.
    Verdenelli MC; Cecchini C; Coman MM; Silvi S; Orpianesi C; Coata G; Cresci A; Di Renzo GC
    Curr Microbiol; 2016 Oct; 73(4):483-90. PubMed ID: 27324341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.
    Stapleton AE; Au-Yeung M; Hooton TM; Fredricks DN; Roberts PL; Czaja CA; Yarova-Yarovaya Y; Fiedler T; Cox M; Stamm WE
    Clin Infect Dis; 2011 May; 52(10):1212-7. PubMed ID: 21498386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational prospective study on Lactobacillus plantarum P 17630 in the prevention of vaginal infections, during and after systemic antibiotic therapy or in women with recurrent vaginal or genitourinary infections.
    Cianci A; Cicinelli E; De Leo V; Fruzzetti F; Massaro MG; Bulfoni A; Parazzini F; Perino A
    J Obstet Gynaecol; 2018 Jul; 38(5):693-696. PubMed ID: 29526145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Activity of Tea Tree Oil Vaginal Suppositories against Candida spp. and Probiotic Vaginal Microbiota.
    Di Vito M; Mattarelli P; Modesto M; Girolamo A; Ballardini M; Tamburro A; Meledandri M; Mondello F
    Phytother Res; 2015 Oct; 29(10):1628-33. PubMed ID: 26235937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the protein-dependent mechanism of Lactobacillus crispatus GAI98322 to prevent recurrent cystitis.
    Watanabe T; Sadahira T; Hirakawa H; Huang P; Zhou T; Iwata T; Sekito T; Ishii A; Watanabe M; Araki M
    J Infect Chemother; 2023 Oct; 29(10):1001-1004. PubMed ID: 37343926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.
    Rostok M; Hütt P; Rööp T; Smidt I; Štšepetova J; Salumets A; Mändar R
    Benef Microbes; 2019 Apr; 10(4):385-393. PubMed ID: 30882242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.
    Rodrigues F; Maia MJ; das Neves J; Sarmento B; Amaral MH; Oliveira MB
    Drug Dev Ind Pharm; 2015; 41(9):1518-25. PubMed ID: 25265366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the effect of vitamin D vaginal suppository on sexual function among postmenopausal women: study protocol for a randomized controlled trial.
    Sarebani Z; Alimoradi Z; Aali E; Mirzadeh M; Chegini V; Abbaspour M; Griffiths MD
    BMC Womens Health; 2020 Feb; 20(1):27. PubMed ID: 32070323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between the vaginal microbiome and Candida colonization in women of reproductive age.
    Tortelli BA; Lewis WG; Allsworth JE; Member-Meneh N; Foster LR; Reno HE; Peipert JF; Fay JC; Lewis AL
    Am J Obstet Gynecol; 2020 May; 222(5):471.e1-471.e9. PubMed ID: 31654610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Onto-phylogenetic prerequisites for development of chronic cystitis in women].
    Kulchavenya E V; Treyvish L S; Telina E V; Tsukanov A Y; Neimark A I; Neimark A B; Kholtobin D P; Razdorskaya M V
    Urologiia; 2023 Dec; (6):30-37. PubMed ID: 38156680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal microbiome.
    Buchta V
    Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection.
    Kwok L; Stapleton AE; Stamm WE; Hillier SL; Wobbe CL; Gupta K
    J Urol; 2006 Nov; 176(5):2050-4; discussion 2054. PubMed ID: 17070251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management.
    Mayersak JS; Viviano CJ
    J Urol; 1993 Apr; 149(4):835-7. PubMed ID: 8384272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis].
    Delia A; Morgante G; Rago G; Musacchio MC; Petraglia F; De Leo V
    Minerva Ginecol; 2006 Jun; 58(3):227-31. PubMed ID: 16783294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.